OpenAlex
PricingAboutJobs
Log inGet started
Work

Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

HTML

Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2008.18.6015
Authors: Ronald B. Natale, David Bodkin, Ramaswamy Govindan, Bethany G. Sleckman, Naiyer A. Rizvi, Adolfo Capó, Paul Germonpré, Wilfried E.E. Eberhardt, Paul K. Stockman, Sarah J. Kennedy, Malcolm Ranson
Institutions: Memorial Sloan Kettering Cancer Center, Sharp Memorial Hospital, University of Duisburg-Essen
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: vandetanib, gefitinib, non-small cell lung cancer, advanced non-small cell lung cancer, VEGFR inhibition, EGFR inhibition, tyrosine kinase inhibitors, progression-free survival, overall survival, second-line therapy, platinum-based chemotherapy, drug safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2114940128
FWCI: 37.05
Cites: 26
Cited by: 233
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms